This theme covers the expansion of domestic and overseas sales of diagnostic reagents and testing equipment, as well as declines in revenue and profit in the overseas testing business due to lower demand for infectious disease test kits in the United States and sluggish market conditions in China. It focuses on region-specific demand fluctuations in the testing business and their impact on performance.